Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
RACHESKY MARK H MD
   2. Issuer Name and Ticker or Trading Symbol
LORAL SPACE & COMMUNICATIONS INC. [LORL] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
40 WEST 57TH STREET, 24TH FLOOR		 3. Date of Earliest Transaction (Month/Day/Year)
04/13/2007
(Street)

NEW YORK, NY 10019		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A-1 Preferred Stock (1) $ 30.1504 04/13/2007   J(1)   505   04/13/2007   (9) Common Stock 5,050 (1) 16,148 I See Footnote (2)
Series A-1 Preferred Stock (1) $ 30.1504 04/13/2007   J(1)   58   04/13/2007   (9) Common Stock 580 (1) 1,867 I See Footnote (3)
Series A-1 Preferred Stock (1) $ 30.1504 04/13/2007   J(1)   251   04/13/2007   (9) Common Stock 2,510 (1) 8,010 I See Footnote (4)
Series A-I Preferred Stock (1) $ 30.1504 04/13/2007   J(1)   631   04/13/2007   (9) Common Stock 6,310 (1) 20,178 I See Footnote (5)
Series A-1 Preferred Stock (1) $ 30.1504 04/13/2007   J(1)   2,963   04/13/2007   (9) Common Stock 29,630 (1) 94,731 I See Footnote (6)
Series B-1 Preferred Stock (1) $ 30.1504 04/13/2007   J(1)   563     (7)   (9) Common Stock (8) 5,630 (1) 98,925 I See Footnote (2)
Series B-1 Preferred Stock (1) $ 30.1504 04/13/2007   J(1)   65     (7)   (9) Common Stock (8) 650 (1) 11,437 I See Footnote (3)
Series B-1 Preferred Stock (1) $ 30.1504 04/13/2007   J(1)   279     (7)   (9) Common Stock (8) 2,790 (1) 49,066 I See Footnote (4)
Series B-1 Preferred Stock (1) $ 30.1504 04/13/2007   J(1)   704     (7)   (9) Common Stock (8) 7,040 (1) 123,614 I See Footnote (5)
Series B-1 Preferred Stock (1) $ 30.1504 04/13/2007   J(1)   3,307     (7)   (9) Common Stock (8) 33,070 (1) 580,362 I See Footnote (6)

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
RACHESKY MARK H MD
40 WEST 57TH STREET
24TH FLOOR
NEW YORK, NY 10019		   X   X    
MHR Capital Partners Master Account LP
40 WEST 57TH STREET
24TH FLOOR
NEW YORK, NY 10019		   X   X    
MHR ADVISORS LLC
40 WEST 57TH STREET
24TH FLOOR
NEW YORK, NY 10019		   X   X    
MHR INSTITUTIONAL PARTNERS LP
40 WEST 57TH STREET
24TH FLOOR
NEW YORK, NY 10019		   X   X    
MHR Institutional Advisors LLC
40 WEST 57TH STREET
24TH FLOOR
NEW YORK, NY 10019		   X   X    
MHR Institutional Partners IIA LP
40 WEST 57TH STREET
24TH FLOOR
NEW YORK, NY 10019		   X   X    
MHR Institutional Advisors II LLC
40 WEST 57TH STREET
24TH FLOOR
NEW YORK, NY 10019		   X   X    
MHR Institutional Partners III LP
40 WEST 57TH STREET
24TH FLOOR
NEW YORK, NY 10019		   X   X    
MHR Institutional Advisors III LLC
40 WEST 57TH STREET
24TH FLOOR
NEW YORK, NY 10019		   X   X    
MHR FUND MANAGEMENT LLC
40 WEST 57TH STREET
24TH FLOOR
NEW YORK, NY 10019		   X   X    

Signatures

 /s/ Mark H. Rachesky, M.D. Mark H. Rachesky, M.D.   04/17/2007
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Since February 27, 2007, the Reporting Persons have owned shares of Series A-1 Cumulative 7.50% Convertible Preferred Stock, par value $0.01 per share, of the Issuer (the "Series A-1 Preferred Stock") and Series B-1 Cumulative 7.50% Convertible Preferred Stock, par value $0.01 per share, of the Issuer (the "Series B-1 Preferred Stock" and, together with the Series A-1 Preferred Stock, the "Preferred Stock"). This Form 4 is being filed to report the receipt of additional shares of Preferred Stock as paid-in-kind interest on the shares of Preferred Stock already held by the Reporting Persons pursuant to their respective terms.
(2) These shares are held for the account of MHR Capital Partners Master Account LP, an Anguilla, British West Indies limited partnership ("Master Account"). MHR Advisors LLC, a Delaware limited liability company ("Advisors"), is the general partner of Master Account. Mark H. Rachesky, M.D. ("Dr. Rachesky") is the managing member of Advisors. In such capacity, Dr. Rachesky may be deemed to be the beneficial owner of the shares held for the account of Master Account. MHR Fund Management LLC ("Fund Management") has an investment management agreement with Master Account pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Master Account and, accordingly, Fund Management may be deemed to beneficially own the shares held for the account of Master Account.
(3) These shares are held for the account of MHR Capital Partners (100) LP, a Delaware limited partnership ("Capital Partners (100)"). Advisors is the general partner of Capital Partners (100). Dr. Rachesky is the managing member of Advisors. In such capacity, Dr. Rachesky may be deemed to be the beneficial owner of the shares held for the account of Capital Partners (100). Fund Management has an investment management agreement with Capital Partners (100) pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Capital Partners (100) and, accordingly, Fund Management may be deemed to beneficially own the shares held for the account of Capital Partners (100).
(4) These shares are held for the account of MHR Institutional Partners II LP, a Delaware limited partnership ("Institutional Partners II"). MHR Institutional Advisors II LLC, a Delaware limited liability company ("Institutional Advisors II"), is the general partner of Institutional Partners II. Dr. Rachesky is the managing member of Institutional Advisors II. In such capacity, Dr. Rachesky may be deemed to be the beneficial owner of the shares held for the account of Institutional Partners II. Fund Management has an investment management agreement with Institutional Partners II pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Institutional Partners II and, accordingly, Fund Management may be deemed to beneficially own the shares held for the account of Institutional Partners II.
(5) These shares are held for the account of MHR Institutional Partners IIA LP, a Delaware limited partnership ("Institutional Partners IIA"). Institutional Advisors II is the general partner of Institutional Partners IIA. Dr. Rachesky is the managing member of Institutional Advisors II. In such capacity, Dr. Rachesky may be deemed to be the beneficial owner of the shares held for the account of Institutional Partners IIA. Fund Management has an investment management agreement with Institutional Partners IIA pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Institutional Partners IIA and, accordingly, Fund Management may be deemed to beneficially own the shares held for the account of Institutional Partners IIA.
(6) These shares are held for the account of MHR Institutional Partners III LP, a Delaware limited partnership ("Institutional Partners III"). MHR Institutional Advisors III LLC, a Delaware limited liability company ("Institutional Advisors III") is the general partner of Institutional Partners III. Dr. Rachesky is the managing member of Institutional Advisors III. In such capacity, Dr. Rachesky may be deemed to be the beneficial owner of the shares held for the account of Institutional Partners III. Fund Management has an investment management agreement with Institutional Partners III pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Institutional Partners III and, accordingly, Fund Management may be deemed to beneficially own the shares held for the account of Institutional Partners III.
(7) The shares of Series B-1 Preferred Stock are convertible into shares of common stock, par value $.01 per share, of the Issuer (the "Common Stock") only upon the Majority Ownership Date, as defined and described further in the Schedule 13D/A filed with the Securities and Exchange Commission by the Reporting Persons on February 28, 2007.
(8) Prior to the Majority Ownership Date, the shares of Series B-1 Preferred Stock are only convertible into shares of Class B-1 Non-Voting Common Stock, par value $0.01, of the Issuer (the "Class B-1 Non-Voting Stock"), provided that the Issuer has filed an amendment to its Certificate of Incorporation authorizing the issuance of the Class B-1 Non-Voting Stock (the "Class B Non-Voting Stock Authorization"). Prior to the Class B Non-Voting Stock Authorization, the shares of Series B-1 Preferred Stock are not convertible into any other securities of the Issuer.
(9) None.
 
Remarks:
Remarks:

The filing of this statement shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of any shares not held directly for his or its account for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.